Clinical Trial Update: Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Kuvan (tetrahydrobiopterin) effects on neurocognitive function, phenylalanine levels, safety, and pharmacokinetics in children with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 3 | Status: COMPLETED | Results posted: 2020-12-22